Yaoyi S. Xiong

Nanchang, 330006, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

KNSTRN knockdown impairs autophagy flux to inhibit bladder cancer progression.

KNSTRN knockdown impairs autophagy flux to inhibit bladder cancer progression.

Journal: iScience

Published: July 14, 2025

Identification of biomarkers associated with mitophagy in bladder cancer.

Identification of biomarkers associated with mitophagy in bladder cancer.

Journal: Scientific reports

Published: May 04, 2025

Clinical research progress of ultrarush immunotherapy

Clinical research progress of ultrarush immunotherapy

Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery

Published: September 07, 2023

Ru-Based Organometallic Agents Bearing Phenyl Hydroxide: Synthesis and Antibacterial Mechanism Study against Staphylococcus aureus.

Ru-Based Organometallic Agents Bearing Phenyl Hydroxide: Synthesis and Antibacterial Mechanism Study against Staphylococcus aureus.

Journal: ChemMedChem

Published: June 13, 2023

A multicenter epidemiological study of acute bacterial meningitis in children

A multicenter epidemiological study of acute bacterial meningitis in children

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: October 08, 2022

Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer.

Characterization of hypoxia response patterns identified prognosis and immunotherapy response in bladder cancer.

Journal: Molecular therapy oncolytics

Published: May 25, 2021

E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability.

E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability.

Journal: Cell death & disease

Published: October 13, 2020

Wild-type IDH1 inhibits the tumor growth through degrading HIF-α in renal cell carcinoma.

Wild-type IDH1 inhibits the tumor growth through degrading HIF-α in renal cell carcinoma.

Journal: International journal of biological sciences

Published: October 12, 2020

KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer.

KNSTRN promotes tumorigenesis and gemcitabine resistance by activating AKT in bladder cancer.

Journal: Oncogene

Published: July 26, 2020

An Epithelial-Mesenchymal Transition (EMT) Preoperative Nomogram for Prediction of Lymph Node Metastasis in Bladder Cancer (BLCA).

An Epithelial-Mesenchymal Transition (EMT) Preoperative Nomogram for Prediction of Lymph Node Metastasis in Bladder Cancer (BLCA).

Journal: Disease markers

Published: July 19, 2020

Identification of autophagy-related genes signature predicts chemotherapeutic and immunotherapeutic efficiency in bladder cancer (BLCA).

Identification of autophagy-related genes signature predicts chemotherapeutic and immunotherapeutic efficiency in bladder cancer (BLCA).

Journal: Journal of cellular and molecular medicine

Published: July 09, 2020

CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.

CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.

Journal: Frontiers in oncology

Published: June 09, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026